Practical Aspects of freeze-drying of pharmaceutical and biological products using non-aquoeous co-solvent systems

Freeze-Drying/Lyophilization of Bharmaceutical and Biological Products

Volumn , Issue , 2004, Pages 239-276

  Teagarden, Dirk L ^a   Baker, David S ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77949832310     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (73)

1. L Rey. Potential prospects in freeze-drying. In: L Rey, JC May, eds. Freeze- drying/lyophilization of Pharmaceuticals and Biological Products. New York: Marcel Dekker, 1999, pp 470-471.
2. DL Teagarden, WJ Petre, PM Gold. Stabilized prostaglandin E. United States Patnent 5,741,523, April 21, 1998.
3. DL Teagarden, WJ Petre, PM Gold. Method for preparing stabilized prostaglandin E. United States Patent 5,770,230, June 23, 1998.
4. T Inoue, H Osatake. A new drying method of biological specimens for scanning electron microscopy: the t-butyl alcohol freeze-drying method. Arch Histol Cytol 51:53-59, 1998.
5. H Akahori, H Ishii, I Nonaka, H Yoshida. A simple freeze-drying device using tert-butyl alcohol for SEM (scanning electron microscopy) specimens. J Electron Microsc 37(6):351-352, 1988.
6. T Hojo. Specimen preparation of the human cerebellar cortex for scanning electron microscopy using a t-butyl alcohol freeze-drying device. Scanning Microsc, Suppl 10 (Science of Biological Specimen Preparation for Micro- scopy):345-348, 1996.
7. R Herman, M Muller. Limits in high-resolution scanning electron microscopy: natural surfaces? Scanning 19:337-342, 1997.
8. Norman S Radin. The preparative isolation of lecithin. J Lipid Res 19(7): 922-924, 1978.
9. EJ Benjamin, GC Visor. Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins. United States Patent 4,837,239, June 6, 1989.
10. B Nuijen, M Bouma, REC Henrar, P Floriano, JM Jimeno, H Talsma, JJ Kettenes van den Bosch, AJR Heck, A Bult, JH Beijnen. Pharmaceutical development of a parenteral lyophilized formulation of the novel antitumor agent aplidine. PDA J Pharm Sci Technol 54(3): 193-208, 2000.
11. DW Flamberg, DL Francis, SL Morgan, GF Wickes. Low temperature vacuum drying of sterile parenterals from ethanol. Bull Parent Drug Assoc. 24(5):209-216, 1970.
12. DC Monkhouse. Tertiary alcohol stabilized E-series prostaglandins. United States Patent 3,927,197, December16, 1975.
13. DS Baker. Unpublished results.
14. H Seager, CB Taskis, M Syrop, TJ Lee. Freeze drying parenterals containing organic solvent - Part 1. Manuf Chem Aerosol News 49(11):43-44, 47-48, 1978.
15. H Seager. Freeze drying parenterals containing organic solvent - Part 2. Manuf Chem Aerosol News 49(12): 59-60, 64, 1978.
16. H Seager. Freeze drying parenterals containing organic solvent - Part 3. Manuf Chem Aerosol News 50(1):40, 42-5, 1979.
17. H Seager. Freeze drying parenterals containing organic solvent - Part 4. Manuf Chem Aerosol News 50(2):41-42, 44-45, 48, 1979.
18. H Seager, CB Taskis, M Syrop, TJ Lee. Structure of products prepared by freeze-drying solutions containing organic solvents. J Parenter Sci Technol 39(4): 161-179, 1985.
19. Y Koyama, M Kamat, RJ De Angelis, R Srinivasan, PP DeLuca. Effect of solvent addition and thermal treatment on freeze drying of cefazolin sodium. J Parenter Sci Technol 42(2):47-52, 1988.
20. K Hasegawa, K Hashi, R Okada. Physiochemical stability of pharmaceutical phosphate buffer solutions I - complexation behaviour of Ca(II) with additives in phosphate buffer solutions. J Parenter Sci Technol 36:128-133, 1982.
21. K Hasegawa, K Hashi, R Okada. Physiochemical stability of pharmaceutical phosphate buffer solutions II - complexation behaviour of Al(III) with additives in phosphate buffer solutions. J Parenter Sci Technol 36:168-173, 1982.
22. K Hasegawa, K Hashi, R Okada. Physiochemical stability of pharmaceutical phosphate buffer solutions IV - prevention of precipitation in parenteral phosphate buffer solutions. J Parenter Sci Technol 36:210-215, 1982.
23. K Hasegawa, K Hashi, R Okada. Physiochemical stability of pharmaceutical phosphate buffer solutions V - precipitation behaviour in phosphate buffer solution. J Parenter Sci Technol 37:38-45, 1983.
24. J Hallet. Nucleation and growth of ice crystals. In: L Rey, ed. Advances in Freeze-drying Lyophilisation. Paris: Hermann, 1966, p 33.
25. H Willemer, Experimental freeze-drying. In: L Rey, JC May, eds. Freeze- drying/lyophilization of Pharmaceuticals and Biological Products. NewYork: Marcel Dekker, 1999, pp 79-119.
26. H Willemer. Low temperature freeze drying of aqueous and non-aqueous solutions using liquid nitrogen. In: SA Goldblith, L Rey, WW Rothmayr, eds. Freeze Drying and Advance Food Technology. New York: Academic Press, 1975, pp 461-477.
27. L Rey. Orientations nouvelles de la lyophilisation. In: L Rey, ed. Research and Development in Freeze-Drying. Paris: Hermann, 1964, pp 630-643.
28. K Kasraian, PP DeLuca. Thermal analysis of the tertiary butyl alcohol-water system and its implications on freeze-drying. Pharm Res 12(4):484-490, 1995.
29. JB Ott, JR Goates, BA Waite. (Solid + liquid) phase equilibria and solid- hydrate formation in water + methyl, + ethyl, + isopropyl, + tertiary butyl alcohols. J Chem Thermodyn 11:739-746, 1979.
30. M Woznyj, HD Liidemann. The pressure dependence of the phase diagram t-butanol/water. Z Naturforsch 40a:693-698, 1985.
31. K Murgatroyd. The freeze drying process. In: P Cameron, ed. Good Pharmaceutical Freeze-Drying Practice. Buffalo Grove, IL: Interpharm Press,1997, pp 55-57.
32. MS Tesconi, K Sepassi, SH Yalkowsky. Freeze-drying above room temperature. J Pharm Sci 88(5):501-506, 1999.
33. M Pikal. Freeze-drying of proteins. Part I: Process design. Biopharm. 3 (September): 18-27, 1990.
34. SL Nail, LA Gatlin. Freeze-drying: principles and practice. In: KE Avis, HA Lieberman, L Lachman, eds. Pharmaceutical Dosage Forms: Parenteral Medications Volume 2. New York: Marcel Dekker, 1993, pp 163-233.
35. S Wittaya-areekul. Freeze-drying from nonaqueous solutions. Mahidol Uni J Pharm Sci 26(1-4):33-43, 1999.
36. PP DeLuca, MS Kamat, Y Koida. Acceleration of freeze-drying cycles of aqueous solutions of lactose and sucrose with tertiary butyl alcohol. Congr Int Technol Pharm, 5th 1:439-447, 1989.
37. K Kasraian. The utilization of tertiary butyl alcohol (TBA) as a mass transfer accelarator in lyophilization. Diss Abstr Int B 54(7):3570, 1994.
38. K Kasraian, PP DeLuca. Effect of tert-butyl alcohol on the resistance of the dry product layer during primary drying. Pharm Res 12(4):491-495, 1995.
39. G Baldi, M Gasco, F Pattarino. Statistical procedures for optimizing the freeze-drying of a model drug in tert-butyl alcohol-water mixtures. Eur J Pharm Biopharm 40(3):138-141, 1994.
40. MD Cise, ML Roy. Improvements in or relating to freeze-drying cephalothin sodium. British Patent 1,589,317, May 13, 1981.
41. MPWM te Booy, RA de Ruiter, ALl de Meere. Evaluation of the physical stability of freeze-dried sucrose-containing formulations by differential scanning calorimetry. Pharm Res 9(1): 109-114, 1992.
42. G Needham. Formulation and processing factor affecting residual solvent levels in TBA/water formulations. Freeze-Drying of Pharmaceuticals and Biologicals, Breckenridge, CO, August 1-4, 2001.
43. UR Desai, AM Klibanov. Assessing the structural integrity of lyophilized protein in organic solvents. J Am Chem Soc 117(14):3940-3945, 1995.
44. WP Olsen. Volatile solvents for drying and microbial kill in the final container - a proposal and a review, with emphasis on t-butanol. Pharm Eng July/August:l 12-117, 1997.
45. KH Wallhausser. Appendix B. Antimicrobial preservation used by the cosmetic industry. In: JJ Kabara, ed. Cosmetic and Drug Preservation. New York: Marcel Dekker, 1984, pp 605-745.
46. A Inoue, K Horikoshi. A Pseudomonas thrives in high concentrations of toluene. Nature 338:264-266, 1989.
47. A Pinazo, L Puigjamer, L Coderch, M Vinas. Butanol resistant mutants of Clostridium acetylbutylicum: isolation and partial characterization. Microbios 73:93-104, 1993.
48. JM Flink. Loss of organic volatiles in freeze-dried carbohydrate solutions. Ph.D. thesis, Massachuetts Institute of Technology, 1970.
49. J Flink, F Gejl-Hansen. Retention of organic volatiles in freeze-dried carbohydrate solutions: macroscopic observations. J Agr Food Chem 20(3): 691-694, 1972.
50. JM Flink, M Karel. Retention of organic volatiles in freeze-dried solutions of carbohydrates. J Agr Food Chem 18(2):295-297, 1970.
51. JM Flink, M Karel. Effects of process variables on retention of volatiles in freeze-drying. J Food Sci 35:444-447, 1970.
52. JM Flink, M Karel. Mechanisms of retention of organic volatiles in freeze- dried systems. J Food Technol 7:199-211, 1972.
53. JM Flink, TP Labuza. Retention of 2-propanol at low concentrations by freeze-drying carbohydrate solutions. J Food Sci 37:617-618, 1972.
54. JM Flink. The retention of volatile components during freeze-drying: a structurally based mechanism. In: SA Goldblith, L Rey, WW Rothmayr, eds. Freeze Drying and Advance Food Technology. New York: Academic Press, 1975, pp 351-372.
55. D Lambert, J Flink, M Karel. Volatile transport in frozen aqueous solutions I: development of a mechanism. Cryobiology 10:41-45, 1973.
56. D Lambert, J Flink, M Karel. Volatile transport in frozen aqueous solutions II: influence of system parameters. Cryobiology 10:52-55, 1973.
57. HAC Thijssen. Effect of process conditions in freeze drying retention of volatile components. In: SA Goldblith, L Rey, WW Rothmayr, eds. Freeze Drying and Advance Food Technology. New York: Academic Press, 1975, pp 373-400.
58. WH Rulkens, HAC Thijssen. Retention of volatile compounds in freeze-drying slabs of malto-dextrin. J Food Technol 7(1):79-93, 1972.
59. S Wittaya-areekul, SL Nail. Freeze-drying of tert-butyl alcohol/water cosolvent systems: effects of formulations and process variables on residual solvents. J Pharm Sci 87(4):491-495, 1998.
60. L Rey, Un development nouveau de la lyophilisation: la cryodessication des systemes non-aqueux. EXPERIENTIA 21:241-246, 1965.
61. L Rey, F Chauffard, M Dousset. Les lyophilisations complexes. In: L Rey, ed. Advances in Freeze Drying Lyophilisation Recherches et Applications Nouvelles. Paris: Hermann, 1996, pp 89-94.
62. DL Teagarden, DS Baker. Practical aspects of lyophilization using non- aqueous co-solvent systems. Eur J Pharm Sci 15:115-133, 2002.
63. WK Hubbard. International Conference on Harmonization; guidance on impurities: residual solvents. Federal Register 62(247):67377-67388, December 1997.
64. PP DeLuca, M Kanke, T Sato, HG Schroeder. Porous microspheres for drug delivery and methods for make same. United States Patent 4,818,542, April 4, 1989.
65. JR Tica Grau, A Del Pozo Carrascosa, R Salazar Macian, S Alonso Ciriza. Determinacion de disolventes residuals en materias primas farmaceuticas: aplicacion en amoxicilinas sodicas liofilzadas. Cienc Ind Farm 7(11):325-330, 1988.
66. N Tanno, N Ae, K Ishizumi. Freeze-dried pharmaceuticals of fat-soluble platinum(II) complexes. Japanese Patent 03255025, March 2, 1990.
67. Y Zou, W Priebe, R Perez-soler. Submicron liposome suspensions obtained from preliposome lyophilizates. United States Patent 5,902,604, May 11, 1999.
68. S Kamijo, A Imai, H Kodaira. Preparation of crystalline lyophilized gabexate mesilate with high stability. Japanese Patent 63270623, April 30, 1987.
69. S Kaneko, M Kishikawa, T Sato, K Maeda. Manufacture of freeze-dried anthracycline glycoside preparations with improved solubility. Japanese Patent 07,0765,15, June 30. 1993.
70. BW Sullivan, PJ Marangos. Partially lyophilized fructose-1,6-diphosphate (FDP) for injection into humans. United States Patent 5,731,291, March 24, 1998.
71. P Meredith, AM Donald, RS Payne. Freeze-drying: in situ observations using cryoenvironmental scanning electron microscopy and differential scanning calorimetry. J Pharm Sci 85:631 637, 1996.
72. PL Feigner, DA Eppstein, Stable liposomes with aqueous-soluble medicaments. European Patent 0172007B1, May 22, 1991.
73. FHJ Jansen. Process to prepare pharmaceutical compositions containing vecuronium bromide. United States Patent 5,681,573, October 28, 1997.